why choose us

First received: January 12, 2023

Clinical Trial: Medicine-induced Cardiac Hemodialysis on COVID-19

Study Status: Completed

Recruit Status: Completed

Condition: Severe Acute Respiratory Syndrome-related Coronavirus
Renal Dialysis
Vaccines
Myocard

Study Type: Interventional


Official Title: Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks

Brief Summary: The clinical trial studies the human pathogen of SARS-CoV-2, with a specificity in the circulating Spike 2 protein in the human system. The clinical trial hypothesizes that SARS-CoV-2 human pathogen arises from immune attacks, underlying the severe physiological symptoms that can be lethal. It further hypothesizes that the vaccines do not deal with the Spike 2 protein that causes the immune attacks.

Read more